Cary D Austin Selected Research

GDC-0334

1/2021

A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cary D Austin Research Topics

Disease

11	Asthma (Bronchial Asthma) 10/2022 - 12/2007
8	Inflammation (Inflammations) 10/2022 - 12/2007
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2017
3	Infections 10/2017 - 01/2016
3	Neoplasms (Cancer) 07/2012 - 12/2004
2	Airway Remodeling 10/2022 - 12/2020
1	Gram-Negative Bacterial Infections 10/2022
1	Eosinophilia 01/2022
1	Pain (Aches) 01/2021
1	Glomerulonephritis 01/2021
1	Edema (Dropsy) 01/2021
1	Cough 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Anaphylaxis (Anaphylactic Shock) 10/2019
1	Proteinuria 01/2017
1	Lupus Nephritis 01/2017
1	Nephritis 01/2017
1	Staphylococcal Infections 01/2016
1	Pneumonia (Pneumonitis) 12/2015
1	Hyperplasia 12/2015
1	Respiratory Hypersensitivity 12/2015
1	Pancreatic Cyst 12/2012
1	Tuberculosis (Tuberculoses) 10/2012
1	Leprosy (Hansen's Disease) 10/2012
1	Granuloma 10/2012
1	Melanoma (Melanoma, Malignant) 07/2012
1	Allergic Rhinitis 12/2007
1	Atopic Dermatitis (Atopic Eczema) 12/2007
1	Breast Neoplasms (Breast Cancer) 12/2004
1	Carcinogenesis 12/2004

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 10/2022 - 01/2012
4	AntibodiesIBA 01/2016 - 12/2005
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2019
3	Phosphotransferases (Kinase)IBA 12/2018 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2012
3	AntigensIBA 12/2015 - 12/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2012
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2017
2	Tryptases (Tryptase)IBA 01/2020 - 10/2019
2	Immunoglobulin E (IgE)IBA 10/2019 - 02/2012
2	OX40 LigandIBA 01/2017 - 12/2007
2	Thymic Stromal LymphopoietinIBA 01/2012 - 12/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	Interleukin-5 (Interleukin 5)IBA 10/2022
1	Interleukin-4 (Interleukin 4)IBA 10/2022
1	Leukotriene E4IBA 10/2022
1	Prostaglandin D2IBA 10/2022
1	Pharmaceutical PreparationsIBA 10/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2022
1	AllergensIBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	SteroidsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	SymportersIBA 01/2021
1	GDC-0334IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	lebrikizumabIBA 12/2020
1	Interleukin-13IBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2020
1	anti-IgE antibodiesIBA 10/2019
1	Type VII Secretion SystemsIBA 10/2017
1	Virulence Factors (Pathogenicity Factors)IBA 10/2017
1	purineIBA 01/2016
1	GuanineIBA 01/2016
1	RiboswitchIBA 01/2016
1	OvalbuminIBA 12/2015
1	Adenosine Monophosphate (AMP)IBA 12/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012
1	Adenosine Triphosphatases (ATPase)IBA 10/2012
1	LigandsIBA 01/2012
1	Immunoconjugates (Immunoconjugate)IBA 12/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004
1	Biological ProductsIBA 12/2004
1	geldanamycinIBA 12/2004
1	Trastuzumab (Herceptin)FDA Link 12/2004

Therapy/Procedure

7	Therapeutics 01/2022 - 12/2004
1	Biological Therapy 10/2022
1	Immunotherapy 07/2012